name of glp 1 drugs GLP-1 medication and its types GLP-1 Agonists: Using Semaglutide, Tirzepatide,

& Hevener, A

Many of the cardiovascular and metabolic trials informing the discussion were not designed to evaluate ophthalmic outcomes. The authors called for prospective ophthalmology-specific studies incorporating imaging biomarkers, visual outcomes and disease-specific monitoring, noting that parsing the protective benefits or adverse effects of this rapidly growing medication class will be essential to refining disease management and improve patient outcomes. As GLP-1 therapies become increasingly common among patients with diabetes, obesity and vascular comorbiditiesprecisely the populations populating ophthalmic clinicsthe field may not have the luxury of waiting for cleaner data

Nonalcoholic fatty liver disease

Buckley STSS, Kirk RK, Knudsen LB